WQ
LGND icon

Wealth Quarterback’s Ligand Pharmaceuticals LGND Stock Holding History

Wealth Quarterback’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$18K Hold
197
– – 0.01% 376
2021
Q2 		$17K Buy
+197
New +$16.4K 0.01% 378
2020
Q2 		– Sell
-213
Closed -$9.67K – 467
2020
Q1 		$9.67K Hold
213
– – 0.01% 480
2019
Q4 		$13.9K Buy
+213
New +$14.2K 0.01% 450

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Wealth Quarterback's LGND Position: Q3 2021 in Review

Wealth Quarterback held its Ligand Pharmaceuticals (LGND) position steady in Q3 2021 at 197 shares worth $18K. The position accounts for 0.01% of the portfolio, ranked #376.

Wealth Quarterback first reported a position in LGND in Q4 2019 and has held it in 4 quarters since. 207 funds tracked by Wall St. Rank hold LGND as of Q3 2021.

  • Wealth Quarterback held 197 shares of Ligand Pharmaceuticals worth $18K as of Q3 2021.
  • Wealth Quarterback left its Ligand Pharmaceuticals share count unchanged in Q3 2021.
  • Ligand Pharmaceuticals made up 0.01% of Wealth Quarterback's portfolio in Q3 2021, its #376 holding.
  • Wealth Quarterback first reported a position in Ligand Pharmaceuticals in Q4 2019 and has held it in 4 quarters since.
  • 207 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2021.

Based on Wealth Quarterback's 13F filing for Q3 2021, filed 17 Nov 2021.